The company also plans to develop its team and boost the portfolio of the products promoted.
„In 2017, the turnover is expected to reach EUR1.2 million from providing medical promotion and telemarketing services (promoting products by phone –e.n.), up 50% against 2016, and sales generated by products promoted by Pharmalink teams are expected to reach EUR4.5 million, which translates into an increase of 80% in sales against 2016,“ Octavian Iacob, co-founder and CEO of Pharmalink, told ZF.